Supplementary Figure 26 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer Biagio Ricciuti , Arielle Elkrief , Joao Alessi , Xinan Wang , Yvonne Li , Hersh Gupta , Daniel M. Muldoon , Arrien A. Bertram , Federica Pecci , Giuseppe Lamberti , Alessandro Di Federico , Adriana Barrichello , Victor R. Vaz , Malini Gandhi , Elinton Lee , Geoffrey I. Shapiro , Hyesun Park , Mizuki Nishino , James Lindsay , Kristen D. Felt , Bijaya Sharma , Andrew D. Cherniack , Scott Rodig , Daniel R. Gomez , Narek Shaverdian , Mehrdad Rakaee , Chaitanya Bandlamudi , Marc Ladanyi , Pasi A. Janne , Adam J. Schoenfeld , Lynette M. Sholl , Mark M. Awad , Michael L. Cheng crossref（2023）
摘要
Supplementary Figure 26. Proportion of (A) tumor, (B) non-tumor, and (C) total PD-L1+ cells according to ATM/TP53 co-mutation status.
更多 查看译文
AI 理解论文
溯源树
样例
